Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CME GROUP INC. Director's Dealing 2023

Mar 17, 2023

29871_dirs_2023-03-17_4331146a-497f-40de-b16b-21eea6a5eebb.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CME GROUP INC. (CME)
CIK: 0001156375
Period of Report: 2023-03-15

Reporting Person: Marcus Jonathan L (Sr MD General Counsel)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-03-15 Common Stock Class A A 2636 $182.67 Acquired 2636 Direct

Footnotes

F1: On March 15, 2023, the reporting person was granted restricted shares, vesting in four equal annual installments on the first four anniversaries of the grant date, subject to the terms and conditions of the CME Group Inc. Omnibus Stock Plan.